China Medical & HealthCare Group Limited provided unaudited consolidated earnings guidance for the four months ended April 30, 2021. For the period, the Group is expected to record a decrease of approximately 76% in loss attributable to shareholders of the Company for the four months ended 30 April 2021 as compared with that for the corresponding period in 2020. This was mainly due to the increase in revenue from the operations of the Healthcare Division and the Eldercare Division; the decreased loss in fair value change of investments held for trading; and an unrealized exchange gain in foreign currency fixed deposits compared with a loss recorded in the corresponding period in 2020.